# Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor

> **NCT07096479** · — · RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 318 (estimated)

## Conditions studied

- Chemotherapy-induced Neutropenia

## Interventions

- **DRUG:** Telpegfilgrastim Injection

## Key facts

- **NCT ID:** NCT07096479
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-15
- **Primary completion:** 2025-08-15
- **Final completion:** 2025-08-15
- **Target enrollment:** 318 (ESTIMATED)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07096479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07096479, "Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07096479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*